PHARMACYTE BIOTECH INC (PMCB) Stock Balance Sheet
NASDAQ:PMCB - Nasdaq - US71715X2036 - Common Stock - Currency: USD
| MRQ (2025-1-31) | 2024 (2024-4-30) | 2023 (2023-4-30) | 2022 (2022-4-30) | 2021 (2021-4-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 16.38M | 50.18M | 68.04M | 85.40M | 2.20M | |||
| Marketable Securities | 372.60K | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 207.40K | 259.80K | 110.00K | 90.00K | 70.00K | |||
| Total Current Assets | 16.96M | 50.44M | 68.15M | 85.49M | 2.28M | |||
| Non-Current Assets | ||||||||
| Investments And Advances | 18.63M | 0.00 | 1.57M | 1.57M | 1.57M | |||
| Intangibles | 1.55M | 1.55M | 3.55M | 3.55M | 3.55M | |||
| Other Non-Current Assets | 3.33M | 5.16M | 10.00K | 10.00K | 10.00K | |||
| Total Non-Current Assets | 26.87M | 9.46M | 5.13M | 5.13M | 5.12M | |||
| TOTAL ASSETS | 43.83M | 59.90M | 73.28M | 90.62M | 7.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | 0.00 | |||
| Accrued Expenses | 709.40K | 735.20K | 460.00K | 500.00K | 550.00K | |||
| Accounts Payable | 485.00K | 389.40K | 130.00K | 210.00K | 170.00K | |||
| Other Current Liabilities | 0.00 | 6.30M | N/A | N/A | N/A | |||
| Total Current Liabilities | 1.19M | 7.42M | 590.00K | 700.00K | 720.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 2.38M | 12.97M | N/A | N/A | N/A | |||
| Total Non-Current Liabilities | 2.38M | 12.97M | 0.00 | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 3.58M | 20.39M | 590.00K | 700.00K | 720.00K | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -96.72M | -115.63M | -115.96M | -111.65M | -107.41M | |||
| Additional Paid In Capital | 181.43M | 185.33M | 202.23M | 201.58M | 114.11M | |||
| Common Shares | 2.20K | 11.87M | 0.00 | 0.00 | 0.00 | |||
| Treasury Stock | -44.43M | -42.04M | -13.56M | N/A | N/A | |||
| Other Shareholders' Equity | -24.50K | -23.50K | -20.00K | -20.00K | -20.00K | |||
| Shares Outstanding | 6.90M | 8.04M | 16.79M | 20.72M | 1.59M | |||
| Tangible Book Value per Share | 5.60 | 3.25 | 4.12 | 4.17 | 1.97 | |||
| Total Shareholders' Equity | 40.25M | 39.51M | 72.69M | 89.92M | 6.68M | |||
| TOTAL LIABILITIES AND EQUITY | 43.83M | 59.90M | 73.28M | 90.62M | 7.40M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 14.20 | 6.80 | 115.51 | 122.13 | 3.17 | |||
| Return On Assets (ROA) | 19.70% | -28.78% | -5.90% | -4.68% | -47.97% | |||
| Return On Equity (ROE) | 21.45% | -43.62% | -5.94% | -4.72% | -53.14% | |||
All data in USD , ROIC based on taxRate of 0.21